CJC-1295 (no DAC)
Short-acting GH pulse boost timed to your body's natural rhythm
Read the full profileDAC (Drug Affinity Complex) is an albumin-binding adduct, not a dose modification. CJC-1295 without DAC is a short-acting GHRH analog; with DAC it lasts days. 'CJC-1295' alone on a label is incomplete identity.
This guide compares the same profile fields for both. It does not decide which is better, recommend either compound, or determine whether switching or combining them is appropriate.
Specimen cards
Short-acting GH pulse boost timed to your body's natural rhythm
Read the full profileLong-acting GH releaser, once or twice weekly
Read the full profileField notes
CJC-1295 (no DAC) is a short-acting GHRH peptide that amplifies your natural growth hormone pulses, especially when paired with Ipamorelin. It boosts release and eases off the somatostatin brake, supporting recovery and body compo...
CJC-1295 with DAC (Drug Affinity Complex) binds to albumin in your blood, extending its half-life to about a week. That means just 1-2 injections weekly produce sustained growth hormone elevation. That's convenient, but the steady...
Generally well-tolerated but can cause water retention and other GH-related effects.
Banned by WADA. May affect thyroid function with prolonged use. Cycle off periodically.
Generally well-tolerated but the sustained GH elevation can cause more water retention and joint pain than pulsatile dosing.
Banned by WADA. The week-long half-life means side effects can persist after stopping. Cycle off periodically.
100 mcg at night fasted
daily
8 weeks on, 8 weeks off
Often paired with Ipamorelin for stronger GH pulses; dose before bed to align with natural overnight release.
1-2 mg per week (typically split into 2 doses)
twice_weekly
8 weeks on, 8 weeks off
Pair with Ipamorelin only on the day of injection. The DAC version's sustained release means daily Ipamorelin combos aren't needed.
The comparison pulls from the live peptide profiles used across The Peptide App. Use it to spot differences in documented context, titration notes, and safety flags. Missing data remains missing rather than being inferred.
CJC-1295 and CJC-1295 with DAC are distinct compounds and can differ in mechanism, documented profile context, titration notes, evidence, and safety flags. The comparison table shows the same stored fields side by side and leaves unavailable information blank.
There is no universal answer, and this page does not rank or recommend either compound. A licensed professional can interpret the evidence, product status, and individual context; this page is only a structured research comparison.
Combining peptides can change dosing complexity and risk. This comparison is not medical advice, and it should not be used to start, stop, or combine protocols. A licensed professional is the right person to evaluate whether any combination is appropriate.
This comparison is for research and educational purposes. It does not diagnose, treat, prescribe, or replace guidance from a licensed professional. Always follow the instructions provided with your product.
Keep dose timing, reminders, and protocol notes together in The Peptide App.
These references come from the CJC-1295 (no DAC) and CJC-1295 (with DAC) peptide profiles. Research cited for one compound does not automatically apply to the other.